Findings

What do systematic reviews say?

4,808 questions · 8,953 findings · 827 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1,891 · 21.1%GRADE not reported 380 · 4.2%Very low 2,100 · 23.5%Low 2,449 · 27.4%Moderate 1,684 · 18.8%High 449 · 5%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Biofeedback plus standard therapy vs usual care

QoL · people with irritable bowel syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Biofeedback for treatment of irritable bowel syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Biofeedback plus standard therapy vs usual care

Adverse events (AE) · people with irritable bowel syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Biofeedback for treatment of irritable bowel syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Biofeedback plus standard therapy vs usual care

SAEs · people with irritable bowel syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Biofeedback for treatment of irritable bowel syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Biofeedback plus standard therapy vs usual care

Abdominal pain · people with irritable bowel syndrome

1 finding from 1 review

Biofeedback for treatment of irritable bowel syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Very low

Biofeedback plus standard therapy vs sham biofeedback plus standard therapy

Clinical remission or improvement · people with irritable bowel syndrome

It is very uncertain whether biofeedback plus standard therapy changes clinical response (adequate improvement or remission) compared with sham biofeedback plus standard therapy (very low certainty).

1 finding from 1 review

Biofeedback for treatment of irritable bowel syndrome 2019 · Cochrane Headline outcomes only
RR 2.33 [1.13, 4.8]
1 study · 20 participants
Very low

Biofeedback plus standard therapy vs sham biofeedback plus standard therapy

QoL · people with irritable bowel syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Biofeedback for treatment of irritable bowel syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Biofeedback plus standard therapy vs sham biofeedback plus standard therapy

Adverse events (AE) · people with irritable bowel syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Biofeedback for treatment of irritable bowel syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Biofeedback plus standard therapy vs sham biofeedback plus standard therapy

SAEs · people with irritable bowel syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Biofeedback for treatment of irritable bowel syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Aromatherapy vs placebo or usual care

Tiredness · people receiving dialysis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Aromatherapy vs placebo or usual care

Exhaustion · people receiving dialysis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Aromatherapy vs placebo or usual care

Asthenia · people receiving dialysis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Aromatherapy vs placebo or usual care

Fatigue · people receiving dialysis

1 finding from 1 review

Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 542 participants
Low

Aromatherapy vs placebo or usual care

Weakness · people receiving dialysis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Aromatherapy vs placebo or usual care

Energy · people receiving dialysis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Radiotherapy vs botulinum toxin

Participant‐reported improvement in sialorrhea in the short term · sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis

1 finding from 1 review

Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 16 participants
Very low

Radiotherapy vs botulinum toxin

Reduction in the amount of saliva production in the short term using an objective measure · sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis

The review found no eligible studies for this question.

1 finding from 1 review

Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Radiotherapy vs botulinum toxin

Quality of life · sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis

The review found no eligible studies for this question.

1 finding from 1 review

Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Radiotherapy vs botulinum toxin

Adverse events, reported as "negative experiences" · sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis

It is very uncertain whether radiotherapy changes adverse events, reported as "negative experiences" compared with botulinum toxin (very low certainty).

1 finding from 1 review

Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis 2022 · Cochrane Headline outcomes only
RR 7 [1.04, 46.95]
1 study · 20 participants
Very low

Phototherapy vs sham light

Clinical cure · bacterial folliculitis and boils (furuncles and carbuncles)

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for bacterial folliculitis and boils (furuncles and carbuncles) 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Phototherapy vs sham light

Severe adverse events leading to withdrawal of treatment · bacterial folliculitis and boils (furuncles and carbuncles)

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for bacterial folliculitis and boils (furuncles and carbuncles) 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found